View Document Preview and Link Document Date: 2013-12-16 21:06:37 Open Document File Size: 67,00 KB Share Result on Facebook
City T7 / / Company IgG / CDCC / Wiley-VCH Verlag GmbH & Co. KGaA / AMD / Ó 2014 Wiley-VCH Verlag GmbH & Co. KGaA / / Continent North America / / Country United States / / Currency AMD / / IndustryTerm formulated drug products / low-protein concentration drug products / hybridoma technology / drug product / eukaryotic expression systems / expression systems / cancer treatment / uorescence resonance energy transfer / recombinant technologies / expanded change protocol / energy dissipation / higher-protein-concentration products / metal chelate chromatography / culture production systems / antibody-related products / chemical degradation reactions / microbial systems / process analytical technology / chemical modifications / / MedicalCondition systemic lupus erythematosus / macular edema / HIV / lymphoma / ankylosing spondylitis / rheumatoid arthritis / macular degeneration / plaque psoriasis / chronic inflammatory / age-related macular degeneration / psoriasis / hypersensitivity / T-cell-mediated autoimmune disease / B-cell lymphomas / hemophilia / psoriatic arthritis / polyarticular juvenile idiopathic arthritis / purpura / cancer / metastatic colorectal cancer / ulcerative colitis / tumor necrosis factor / juvenile idiopathic arthritis / infection / idiopathic thrombocytopenic purpura / periodic syndrome / / MedicalTreatment antibiotics / renal transplant / / Organization US Federal Reserve / FDA / European Union / Center for Drug Evaluation and Research / V (FV) / / Person Thomas Ryll / Deborah Farson / Henry B. Lowman / Steven M. Chamow / / Position Major / / Product Amevive / vitamin K / mannitol / Orencia / Orthoclone OKT / valproic acid / glycine / sorbitol / / Technology ADC / 1 hybridoma technology / antibodies / biotechnology / 208 process analytical technology / process control / 351 recombinant technologies / monomeric Fc technology / pharmacokinetics / drug delivery / 27 expanded change protocol / crystallization / spectroscopy / pharmacodynamics / genotype / / SocialTag 
j371 Index a abatacept 49, 67, 97, 118, 220, 227, 228, 302 – characterization 285–288, 291–294